Besides dividing the patients regarding the presence or absence of axillary lymph node invasion, we have also divided them regarding breast cancer subtype (ER+, HER2+, or TNBC), grade (G1, G2, or G3), age (<50 years old or >50 years old), tumor dimension (<20 or >20 mm) and body mass index (low, normal or overweight). The gene discussed is ERBB2; the disease is breast cancer.